Stockreport

Vyriad Secures Final $25M Series B Tranche to Advance In Vivo CAR T Candidate into Clinic [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF ROCHESTER, Minn., December 23, 2025 BUSINESS WIRE )--Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other ser [Read more]